Ninth Annual Meeting of the Society of Hematologic Oncology (SOHO 2021)
In-Person and Virtual Hybrid Meeting: September 8-11, 2021
This accredited continuing education (CE) activity is jointly provided by Medical Learning Institute, Inc. and The Society of Hematologic Oncology.
Grant support is being solicited from multiple supporters and support will be acknowledged in the course materials.
This accredited CE activity is directed towards physicians, fellows, nurses, physician assistants, pharmacists, and students interested in Hematology Oncology, Medical Oncology and Internal Medicine.
After completing this accredited CE activity, the participant should be better able to:
- Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of hematologic malignancies.
- Debate the benefits of maintenance therapies in patients with hematologic malignancies while integrating key findings into clinical practice to improve patient care.
- Describe the clinical and molecular facets of biology, pathogenesis, diagnostic approaches and therapeutic modalities available for various hematologic disorders.
- Apply novel interprofessional team-based treatment strategies for patients with hematologic malignancies while evaluating the practical utility of novel agents based on data from recent clinical studies to improve outcomes.
- Differentiate the evolving therapeutic strategies for first-line, second-line, third-line, and salvage treatment of hematologic malignancies in order to apply these strategies into practice.
Please see Program page.
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and The Society of Hematologic Oncology. Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 31.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 31.50 Medical Knowledge MOC points and 31.50 Patient Safety MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
PAs may claim a maximum of 31.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Continuing Pharmacy Education
Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Medical Learning Institute, Inc. designates this continuing education activity for 31.50 contact hour(s) (3.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0468-9999-21-005-L01-P
Type of Activity: Knowledge
Nursing Continuing Professional Development
Medical Learning Institute, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Successful completion of this nursing continuing professional development activity will be awarded 31.50 contact hour(s). Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc., is committed to providing high quality accredited continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this accredited CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this accredited CE activity, regardless of the amount or their view of the relevance to the accredited education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the accredited CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
Free to SOHO members for participating in or receiving credit for this accredited activity.
A statement of credit will be issued only upon completion of the online application for credit. You will receive your certificate from Medical Learning Institute, Inc. (MLI). For questions regarding the credit for this activity, please contact MLI at firstname.lastname@example.org. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Please note that if you are requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number and DOB (MM/DD). A score of 70% or higher is needed to obtain MOC credit.
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks, view your participation record at the NABP website: https://nabp.pharmacy/.